The value of the combination of hemoglobin, albumin, lymphocyte and platelet in predicting platinum-based chemoradiotherapy response in male patients with esophageal squamous cell carcinoma-Reference-Cited by-同舟云学术

The value of the combination of hemoglobin, albumin, lymphocyte and platelet in predicting platinum-based chemoradiotherapy response in male patients with esophageal squamous cell carcinoma

Published:2017-05 Issue: Volume:46 Page:75-79
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Cong Lihong,Hu Likuan

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference32 articles.

1. Neoadjuvantchemoradiotherapy for resectable esophageal cancer: an in-depth study of randomized controlled trials and literature review;Duan;Cancer Biol. Med.,2014

2. Global cancer statistics, 2012;Torre;CA Cancer J. Clin.,2015

3. Esophageal cancer statistics in China, 2011: estimates based on 177 cancer registries;Zeng;Thorac. Cancer.,2016

4. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of esophagus;Herskovic;N. Engl. J. Med.,1992

5. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group;Cooper;JAMA,1999

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hemoglobin-Albumin-Lymphocyte-Platelet (HALP) score as a predictive value of Incidental prostate cancer for patients going for Transurethral resection of the prostate (TURP): A Single Center Study;2024-01-24

2. Low HALP (Hemoglobin, Albumin, Lymphocyte, and Platelet) Score Increases the Risk of Post-Stroke Cognitive Impairment: A Multicenter Cohort Study;Clinical Interventions in Aging;2024-01

3. The Novel Biomarkers-Based HALP (Hemoglobin, Albumin, Lymphocyte and Platelet)-Prognostic Model for Acute and Subacute Patients with Cerebral Venous Sinus Thrombosis: A Retrospective Cohort Study;Journal of Atherosclerosis and Thrombosis;2023-11-01

4. Predictive values of the hemoglobin, albumin, lymphocyte and platelet score (HALP) and the modified -Gustave Roussy immune score for esophageal squamous cell carcinoma patients undergoing concurrent chemoradiotherapy;International Immunopharmacology;2023-10

5. Development and Validation of a Recurrence-Free Survival Prediction Model for Locally Advanced Esophageal Squamous Cell Carcinoma with Neoadjuvant Chemoradiotherapy;Annals of Surgical Oncology;2023-09-26